New Cancer Genome Interpreter Platform
We are excited to announce the release of the new Cancer Genome Interpreter (CGI) Platform, accessible through the updated www.cancergenomeinterpreter.org website. The CGI Platform has been developed [...]
We are excited to announce the release of the new Cancer Genome Interpreter (CGI) Platform, accessible through the updated www.cancergenomeinterpreter.org website. The CGI Platform has been developed [...]
Our latest study about somatic mutations in the human bladder is now published in Nature. Using ultradeep DNA duplex sequencing we can measure the clonal landscape of [...]
A new computational method developed in our lab, Oncodrive3D, has been published in Nucleic Acids Research. The article, titled "Oncodrive3D: fast and accurate detection of structural clusters [...]
A study by our group that identified five key factors that are significantly associated with the response of cancer patients to immunotherapy was published in Nature Genetics. [...]
We are very happy to announce that a dual new release of intOGen and boostDM is out. We collected data from 33,218 tumors, resulting in 633 driver [...]
Our latest work to identify mutations that drive clonal hematopoiesis (CH) has been published in the journal Cancer Discovery. We developed machine learning models to identify the [...]
We studied the cases of four children who have experienced two cancers during childhood to address the origin of second pediatric cancers. As a tool, the research [...]
CANCER PROMOTION: understanding cancer promotion to inform prevention Link to the video Nuria Lopez-Bigas, jointly with Allan Balmain (UCSF) and Paul Brennan (IARC) is organizing the next [...]
intOGen is out. In this release we have increased the number of cohorts and samples, we have made small updates to the IntOGen pipeline and we have [...]
We have launched the new website for the EU funded project CGI-Clinics coordinated by Nuria Lopez-Bigas. CGI-Clinics is a community-driven project that aims to improve precision [...]